Dermatillomania Clinical Trial
Official title:
A Double-Blind Study of Lamictal in Neurotic Excoriation
The goal of the proposed study is to evaluate the comparative efficacy of Lamictal (lamotrigine) to placebo in neurotic excoriation. Thirty subjects with neurotic excoriation will receive 12 weeks of double-blind treatment with Lamictal (lamotrigine) or matching placebo. The hypothesis to be tested is that Lamictal (lamotrigine) will be more effective than placebo in patients with neurotic excoriation. The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.
The study will consist of 12 weeks of double-blind treatment with Lamictal (lamotrigine) compared to placebo (1:1) in 30 subjects with neurotic excoriation. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01063348 -
N-Acetyl Cysteine in Pathologic Skin Picking
|
Phase 2 | |
| Completed |
NCT04792645 -
Memantine in Body Focused Repetitive Behaviors
|
Phase 2 | |
| Not yet recruiting |
NCT05545891 -
Aripiprazole in Body Focused Repetitive Behaviors
|
Phase 2 |